Loading…
TELA Bio, Inc. is projected to decline to $0.8154 by 2027, a -4% move from its current price of $0.847. TELA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.8015 | $0.8465 | $0.8939 | -0.06% |
| Jul 14 | $0.7831 | $0.8459 | $0.9138 | -0.13% |
| Jul 15 | $0.7692 | $0.8454 | $0.9292 | -0.19% |
| Jul 16 | $0.7575 | $0.8449 | $0.9423 | -0.25% |
| Jul 17 | $0.7474 | $0.8443 | $0.9539 | -0.31% |
| Jul 18 | $0.7382 | $0.8438 | $0.9645 | -0.38% |
| Jul 19 | $0.7299 | $0.8433 | $0.9743 | -0.44% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.7299 | $0.8433 | $0.9743 | -0.44% |
| Week 2 | $0.6845 | $0.8396 | $1.03 | -0.88% |
| Week 3 | $0.6509 | $0.8359 | $1.07 | -1.31% |
| Week 4 | $0.6235 | $0.8322 | $1.11 | -1.74% |
| Week 5 | $0.60 | $0.8286 | $1.14 | -2.18% |
| Week 6 | $0.5792 | $0.8249 | $1.17 | -2.60% |
| Week 7 | $0.5605 | $0.8213 | $1.20 | -3.03% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
TELA Bio, Inc. is a commercial-stage medical technology company focused on soft-tissue reconstruction solutions that prioritize preservation and restoration of the patient’s anatomy.
The company offers a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; OviTex PRS Reinforced Tissue Matrix products to address unmet needs in plastic and reconstructive surgery; and OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs.
It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
TELA Bio, Inc. (TELA) currently trades at $0.858 and has a market capitalization of $38.41M.
The stock ranks 4689 by market capitalization, placing it among smaller-cap listings in the market.
The overall price outlook is mixed near term with a neutral bias in 2026 and an improving trajectory into the 2030s, as reflected by the year-by-year forecast where long-term averages rise toward bull targets.
A major floor 33.9% below — a decisive break under it would weaken the trend.
The nearest floor, 16.6% below — buyers have tended to step in here.
The nearest ceiling, 14.5% above — a clean break opens room to run.
A major ceiling 33.4% above — clearing it would confirm fresh momentum.
Key TELA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TELA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.837 | Buy | $0.828 | Buy |
| MA 10 | $0.7813 | Buy | $0.8094 | Buy |
| MA 20 | $0.8012 | Buy | $0.8125 | Buy |
| MA 50 | $0.8817 | Sell | $0.8295 | Buy |
| MA 100 | $0.8046 | Buy | $0.8681 | Sell |
| MA 200 | $0.9966 | Sell | $1.06 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.41 | Neutral |
| Stoch RSI (14) | 75.63 | Neutral |
| CCI (20) | 58.47 | Neutral |
| Williams %R (14) | -25.00 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 7.76 | Buy |
| Bollinger %B (20,2) | 0.68 | Neutral |
| Stochastic %K (14) | 75.00 | Neutral |
| TRIX (15) | -0.46 | Sell |
| Awesome (5,34) | -0.00 | Sell |
| Ultimate (7,14,28) | 58.05 | Neutral |
| Momentum (10) | 0.11 | Buy |
| Aroon Osc (25) | -44.00 | Sell |
| Hull MA (9) | 0.87 | Sell |
| ADX (14) | 10.99 | Neutral |
| ATR (14) | 0.04 | Info |
The 30-day technical picture is neutral, with RSI(14) at 50 and moving averages near the current price: SMA50 at $0.8804 and SMA200 at $1.00.
Key near-term support sits at $0.706 and resistance at $0.97, framing a 30-day range from $0.5922 to $1.24.
Annualized volatility stands at 100%, underscoring the high variability in this stock’s near-term path.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.56 | $0.847 | $1.10 | 0% | Neutral | |
| $0.5917 | $0.8154 | $1.22 | -4% | Neutral | |
| $0.5663 | $0.8294 | $1.32 | -2% | Neutral | |
| $0.5045 | $0.7784 | $1.30 | -8% | Neutral | |
| $0.6757 | $1.09 | $1.90 | +29% | Bullish | |
| $0.8479 | $1.43 | $2.57 | +69% | Bullish | |
| $0.7562 | $1.33 | $2.47 | +57% | Bullish | |
| $0.7573 | $1.39 | $2.65 | +64% | Bullish | |
| $0.7007 | $1.34 | $2.61 | +58% | Bullish | |
| $0.6087 | $1.21 | $2.41 | +43% | Bullish | |
| $0.9388 | $2.09 | $4.58 | +146% | Bullish | |
| $1.46 | $3.24 | $7.44 | +282% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.56 | $0.847 | $1.01 | +0.00% |
| August 2026 | $0.6396 | $0.7747 | $0.9772 | -8.54% |
| September 2026 | $0.6511 | $0.7998 | $1.03 | +3.24% |
| October 2026 | $0.6679 | $0.8306 | $1.09 | +3.84% |
| November 2026 | $0.6402 | $0.8044 | $1.07 | -3.15% |
| December 2026 | $0.6428 | $0.8155 | $1.10 | +1.39% |
Click any year to see its month-by-month TELA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
TELA Bio, Inc.'s 2026 outlook centres on $0.847, within a $0.56 to $1.10 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, TELA could reach as high as $1.22, with a base case around $0.8154 and support toward $0.5917 — roughly -4% from $0.847. Price action looks broadly range-bound.
Expect TELA to range from $0.5663 to $1.32 through 2028. The $0.8294 average target implies a -2% move from current prices. That is up +2% on the projected 2027 average. A consolidation phase looks the most probable path here.
The TELA price prediction for 2029 points to an average of $0.7784 (low $0.5045, high $1.30) — a potential decline of -8% on today's $0.847. Price action looks broadly range-bound.
In 2030, TELA is projected to trade between $0.6757 and $1.90, averaging $1.09 — a potential gain of +29% from today's $0.847. That is up +40% on the projected 2029 average. Buyers look set to stay in control over this stretch.
TELA Bio, Inc.'s 2031 outlook centres on $1.43, within a $0.8479 to $2.57 range. That is up +31% on the projected 2030 average. That marks a +69% change versus current levels. Momentum favours further upside here.
By 2032, TELA could reach as high as $2.47, with a base case around $1.33 and support toward $0.7562 — roughly +57% from $0.847. Buyers look set to stay in control over this stretch.
Expect TELA to range from $0.7573 to $2.65 through 2033. The $1.39 average target implies a +64% move from current prices. That is up +4% on the projected 2032 average. Momentum favours further upside here.
The TELA price prediction for 2034 points to an average of $1.34 (low $0.7007, high $2.61) — a potential gain of +58% on today's $0.847. Buyers look set to stay in control over this stretch.
In 2035, TELA is projected to trade between $0.6087 and $2.41, averaging $1.21 — a potential gain of +43% from today's $0.847. That is -10% versus the projected 2034 average. Momentum favours further upside here.
TELA Bio, Inc.'s 2040 outlook centres on $2.09, within a $0.9388 to $4.58 range. That is up +73% on the projected 2035 average. That marks a +146% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, TELA could reach as high as $7.44, with a base case around $3.24 and support toward $1.46 — roughly +282% from $0.847. Momentum favours further upside here.
Investing $1,000 in TELA today (≈ 1,180.637544 TELA) could be worth
$3,821.35
+$2,821.35 (+282%) by 2050 · US Dollar
Based on the average projected TELA price of $3.24 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TELAwould be worth at today's price.
$1,000 invested in TELA on Jul 10, 2025 (≈ 483.091803 TELA) would be worth
$409.18
-$590.82 (-59.1%) today · 0.41× · US Dollar
Based on a TELA entry price of $2.07 vs. today's $0.847.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.721 | $1,174.76 | +17.5% |
| 1 month ago | $0.942 | $899.15 | -10.1% |
| 3 months ago | $0.567 | $1,493.83 | +49.4% |
| 6 months ago | $1.06 | $799.06 | -20.1% |
| 1 year ago | $2.07 | $409.18 | -59.1% |
| All time (5.0y) ago | $15.36 | $55.14 | -94.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TELA forecast.
Our base-case forecast reaches $1.70 around 2040.
Implied market cap at $1.70: $76.1M
The multi-year forecast shows a shift from neutral in the near term to bullish in the longer term. In 2026 the average is $0.858 with a range from $0.56 to $1.12 and ROI of 0%, reflecting a neutral sentiment.
From 2030 onward, the outlook becomes more constructive, with 2030 average $1.11 and a max of $1.93, yielding a 29.6% ROI and a bullish sentiment. The trajectory continues with 2031 average $1.46 and ROI 69.8%, 2032 average $1.36 and ROI 58.1%, 2033 average $1.41 and ROI 64.3%, 2034 average $1.35 and ROI 57.4%, and 2035 average $1.22 and ROI 42.3%, all carrying bullish sentiment.
In 2040 the forecast envisions an average price of $2.11 with a max of $4.62 and a ROI of 145.4%, continuing the bullish trend. The 2050 forecast shows an average of $3.30 with a max of $7.58 and a ROI of 284.2%, remaining bullish.
These are estimates, not guarantees, and reflect modeled expectations with inherent uncertainty.
Tap a question to reveal the answer.
Average price $1.11, min $0.6873, max $1.93, ROI 29.6%, sentiment BULLISH.
Near-term outlook is NEUTRAL in 2026 with ROI 0% and negative ROIs in 2027-2029, but the longer-term view turns BULLISH, with projected ROIs of 29.6% in 2030, 69.8% in 2031, 145.4% in 2040 and 284.2% in 2050.
Yes. The forecast maximum for 2040 is $4.62, which exceeds $4.
Current price $0.858; 30-day range low $0.5922 and high $1.24.
Average $3.30, min $1.48, max $7.58, ROI 284.2%, sentiment BULLISH.
TELA Bio, Inc. Community Discussion
0Share your TELA Bio, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.